Sort
48,018 grants matching “immunotherapy”
Engineered Immune Cells for T1D
$791,321Everett Meyer · Stanford University · R01 · FY2022 · DK
MHC Variation in Host Response to SARS-CoV2 and COVID-19 Outcomes
$791,237Jill Allison Hollenbach · University Of California, San Francisco · R01 · FY2022 · AI
Epigenome-wide association study of childhood asthma
$790,887Pandurangan Vijayanand · La Jolla Institute For Immunology · R01 · FY2020 · AI
Targeting Blys/Baff in non-human primate islet transplantation
$790,472Ali Naji · University Of Pennsylvania · U01 · FY2014 · AI
EPITOPE BASED DNA VACCINES FOR AIDS THERAPY
$790,138Idm Pharma, Inc. · P01 · FY2002 · AI
Control of Cytokine Gene Expression in LymphoidMyeloid Cells
$790,108Howard Young · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
HIV Persistence and Renewal in the Gastrointestinal, Genitourinary and Adipose Tissues
$789,998David Mitchell Smith · University Of California, San Diego · R01 · FY2021 · DK
Engineering knotted peptide therapeutics for pediatric brain tumor patients
$789,957James M Olson · Fred Hutchinson Cancer Research Center · R01 · FY2021 · CA
PROJECT 2: Development and Refinement of Predictive Models for Designing Immunotherapy Combination Treatments
$789,891Vesteinn Thorsson · Institute For Systems Biology · U54 · FY2022 · CA
Novel Approaches to Targeting Cancers Associated with VHL Mutations
$789,660Ramaprasad Srinivasan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Targeting microbial triggers of gammopathy for immunoprevention
$789,579Madhav V Dhodapkar · Emory University · UG3 · FY2024 · CA
Immunophysiological Mechanisms in the Biological Therapy of Cancer
$789,445Robert Wiltrout · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Johns Hopkins Rheumatic Diseases Resource-based Core Center (Johns Hopkins RDRCC)
$789,391Antony Rosen · Johns Hopkins University · P30 · FY2024 · AR
Hepatitis C: Studies of Immunity and Pathogenesis
$789,384Charles M. Rice · Rockefeller University · U19 · FY2007 · AI
Hepatitis C: Studies of Immunity and Pathogenesis
$789,280Charles M. Rice · Rockefeller University · U19 · FY2006 · AI
Project 1: Perturbation of Pre-Existing Immunity to Chronic Viral Infection Through Immunotherapy
$789,106Georg Michael Lauer · Massachusetts General Hospital · U19 · FY2020 · AI
Early diagnosis and mechanistic studies of type 1 diabetes using single cell analysis
$789,010Luc Teyton · Scripps Research Institute, The · R01 · FY2020 · DK
Post-exposure immunotherapy for ricin exposure
$788,841Miles Burke Brennan · Zabbio, Inc. · R44 · FY2021 · AI
Characteristics and protective efficacy of human antibodies against M. tuberculosis
$788,818Jacqueline Michele Achkar · Albert Einstein College Of Medicine · R01 · FY2019 · AI
MHC Variation in Host Response to SARS-CoV2 and COVID-19 Outcomes
$788,776Jill Allison Hollenbach · University Of California, San Francisco · R01 · FY2024 · AI
Early diagnosis and mechanistic studies of type 1 diabetes using single cell analysis
$788,774Luc Teyton · Scripps Research Institute, The · R01 · FY2021 · DK
Risk prediction and longitudinal assessment of cardiotoxicity and functional capacity trajectory in NSCLC patients
$788,652Zhongxing Liao · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · HL
Lung Cancer Care Outcomes/Surveillance Consortium-Iowa
$788,574University Of Iowa · U01 · FY2004 · CA
Early diagnosis and mechanistic studies of type 1 diabetes using single cell analysis
$788,462Luc Teyton · Scripps Research Institute, The · R01 · FY2022 · DK
Identification of human tumor-associated antigens
$788,196Kwong Yok Tsang · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA